source
- Regeneron backs $75M series A for antibody upstart InfinimmuneInfinimmune has amassed further fuel to power its antibody discovery engine, netting a $75 million series A headlined by Regeneron’s venture arm.Fierce Biotech · 1d ago↗ source
- ‘We are proud to be in the lead’: Vaderis lands $152M for phase 3 study in rare blood vessel disorderVaderis Therapeutics has secured an oversubscribed $152 million series B financing to propel the Swiss biotech's AKT inhibitor through phase 3 with the aim of bringing the first treatment for a rar…Fierce Biotech · 1d ago↗ source
- Novo Nordisk partners with Amazon Web Services to boost AI-driven drug discovery, opens London hubNovo Nordisk announced a partnership with Amazon Web Services aimed at using artificial intelligence to speed up the discovery of new medicines. The collaboration will see AWS become Novo Nordisk's…